Table 2.

Hazard ratios for the disease free survival in stage III melanoma patients.

Model	HR	95% CI Lower	95% CI Upper	P-value
Univariable model	2.99	1.50	5.94	0.002
Multivariable model*	3.82	1.26	11.56	0.018

*Adjusted for age of diagnosis, gender, site of melanoma, stage IIIA, B or C status, lymph node status (N stage), adjuvant therapy, the tumor size (T stage), ulceration status, white blood cell counts, tumor-infiltrating lymphocytes (TILs), and the Breslow depth.